Metrics to compare | ATANA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipATANAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −0.4x | −0.4x | |
PEG Ratio | −0.01 | 0.08 | 0.00 | |
Price/Book | 0.4x | 2.0x | 2.6x | |
Price / LTM Sales | 2.7x | 3.2x | 2.9x | |
Upside (Analyst Target) | - | 2.3% | 58.0% | |
Fair Value Upside | Unlock | 8.0% | 9.5% | Unlock |
Attana AB (publ) operates as a life science and diagnostics company in Sweden. The company offers contract research services; Attana Cell 250, an analytical instrument; biosensor chips, reagents, and buffers; and Attana Virus Analytics, a diagnostic application. Its products and services are used in antibody development, vaccine development, cell-based assays, immunogenicity studies, infectious diseases, biological interaction analysis, drug discovery and development, and translational research applications. The company was founded in 2002 and is based in Sollentuna, Sweden.